CLINICAL_TRIALS
trial_result
· 2012-04-13
Clinical Trial Update: Diabetic Retinopathy Candesartan Trials [Phase 3]
Summary
Phase 3 candesartan trials for diabetic retinopathy in Type 1 diabetes have completed, with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Type 1 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2012-04-13